S John Weisnagel Selected Research

S John Weisnagel Research Topics

Disease

22	Insulin Resistance 03/2021 - 02/2003
14	Type 2 Diabetes Mellitus (MODY) 09/2019 - 10/2004
9	Gestational Diabetes (Gestational Diabetes Mellitus) 03/2019 - 05/2011
5	Glucose Intolerance 09/2016 - 10/2004
4	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2020 - 01/2013
4	Obesity 09/2016 - 01/2008
3	Overweight 01/2020 - 12/2008
3	Inflammation (Inflammations) 09/2016 - 12/2008
3	Hypoglycemia (Reactive Hypoglycemia) 01/2013 - 08/2005
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 02/2009 - 01/2006
2	Cardiovascular Diseases (Cardiovascular Disease) 05/2018 - 10/2004
2	Body Weight (Weight, Body) 01/2012 - 10/2010
1	Diabetes Mellitus 02/2020
1	Prediabetic State (Prediabetes) 09/2019
1	Snoring 03/2014
1	Hypertension (High Blood Pressure) 03/2014
1	Apnea 03/2014
1	Acute-Phase Reaction 01/2013
1	Birth Weight (Birth Weights) 11/2011
1	Body Weight Changes 10/2010
1	Gestational Weight Gain 01/2010
1	Metabolic Diseases (Metabolic Disease) 01/2008
1	Atherosclerosis 04/2007
1	Weight Loss (Weight Reduction) 01/2005

Drug/Important Bio-Agent (IBA)

26	Glucose (Dextrose)FDA LinkGeneric 09/2019 - 02/2003
14	Insulin (Novolin)FDA Link 02/2020 - 02/2003
4	Interleukin-6 (Interleukin 6)IBA 01/2018 - 05/2011
3	C-PeptideIBA 09/2019 - 10/2004
3	HDL CholesterolIBA 01/2018 - 10/2004
3	C-Reactive ProteinIBA 01/2018 - 08/2008
3	LipidsIBA 01/2018 - 01/2012
3	Proteins (Proteins, Gene)FDA Link 08/2012 - 11/2007
3	Triglycerides (Triacylglycerol)IBA 02/2009 - 10/2004
2	Insulin Glargine (Lantus)FDA Link 02/2020 - 01/2013
2	Liraglutide FDA Link 01/2020 - 01/2018
2	AdiponectinIBA 01/2018 - 09/2016
2	HDL-triglycerideIBA 01/2018 - 08/2008
2	CarbohydratesIBA 01/2014 - 01/2010
2	LDL Lipoproteins (beta Lipoproteins)IBA 08/2008 - 04/2007
1	Bile Acids and Salts (Bile Acids)IBA 03/2021
1	Butyrates (Butyrate)IBA 02/2021
1	Cholecalciferol (Vitamin D3)FDA Link 09/2019
1	hydroxide ionIBA 09/2019
1	Vitamin D FDA LinkGeneric 09/2019
1	25-hydroxyvitamin DIBA 09/2019
1	Glucagon-Like Peptide-1 Receptor AgonistsIBA 05/2018
1	Estrogens (Estrogen)FDA Link 01/2018
1	CytokinesIBA 01/2018
1	VLDL CholesterolIBA 01/2018
1	Estradiol (Delestrogen)FDA LinkGeneric 01/2018
1	LeptinIBA 09/2016
1	Citrate (si)-Synthase (Synthase, Citrate)IBA 09/2015
1	Glucagon-Like Peptide 1 (GLP 1)IBA 09/2014
1	Sitagliptin Phosphate (Januvia)FDA Link 09/2014
1	Cell Adhesion MoleculesIBA 09/2014
1	Oxygen (Dioxygen)IBA 03/2014
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 09/2013
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2013
1	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 01/2013
1	Calcitriol Receptors (Calcitriol Receptor)IBA 01/2013
1	InterleukinsIBA 01/2013
1	Blood Glucose (Blood Sugar)IBA 01/2013
1	Interleukin-10 (Interleukin 10)IBA 01/2013
1	Retinoid X Receptors (Retinoid X Receptor)IBA 01/2013
1	Triggering Receptor Expressed on Myeloid Cells-1IBA 01/2013
1	Liver X ReceptorsIBA 01/2013
1	insulin glulisine FDA Link 01/2013
1	TabletsIBA 08/2012
1	Hypoglycemic Agents (Hypoglycemics)IBA 08/2012
1	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 01/2012
1	Sex Hormone-Binding GlobulinIBA 11/2011
1	T-18 (T 18)IBA 10/2010
1	Nonesterified Fatty Acids (NEFA)IBA 02/2009
1	Dietary Fats (Dietary Fat)IBA 01/2009
1	mu Opioid Receptors (mu Opioid Receptor)IBA 09/2008
1	Opioid Analgesics (Opioids)IBA 09/2008
1	ApolipoproteinsIBA 08/2008
1	Biomarkers (Surrogate Marker)IBA 01/2008
1	oxidized low density lipoproteinIBA 04/2007
1	Adenosine Triphosphate (ATP)IBA 01/2006
1	CholesterolIBA 01/2006
1	InsulinsIBA 08/2005
1	Hormones (Hormone)IBA 03/2005

Therapy/Procedure

5	Therapeutics 02/2020 - 03/2005
2	Glycemic Control 07/2019 - 01/2014
1	Bariatric Surgery 08/2017